Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 753.20 INR
Change Today -13.85 / -1.81%
Volume 16.9K
EMER On Other Exchanges
Symbol
Exchange
Natl India
As of 7:06 AM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

merck ltd (EMER) Snapshot

Open
761.05
Previous Close
767.05
Day High
775.00
Day Low
750.70
52 Week High
04/8/15 - 1,009
52 Week Low
12/1/14 - 670.00
Market Cap
12.5B
Average Volume 10 Days
41.5K
EPS TTM
26.04
Shares Outstanding
16.6M
EX-Date
03/30/15
P/E TM
28.9x
Dividend
6.00
Dividend Yield
0.80%
Current Stock Chart for MERCK LTD (EMER)

Related News

No related news articles were found.

merck ltd (EMER) Related Businessweek News

No Related Businessweek News Found

merck ltd (EMER) Details

Merck Limited manufactures and markets pharmaceuticals, bulk drugs, fine chemicals, and pigments in India. The company operates through two segments, Pharmaceuticals and Chemicals. The Pharmaceuticals segment offers multi-vitamin products under the Evion and Polybion; Concor for cardio-vascular care; Carbophage to treat metabolic disorders; Livogen for haematinics; and immuno-stimulators under the brands Immubron and Pedimune. It also provides consumer health care products, including vitamin B, cough and cold, and health protection and children health products under the Neurobion, Nasivion, Seven Seas, Electrobion, Maxepa, and Evion Cream brands. In addition, this segment exports its products to Asian and African countries, including Sri Lanka, Nepal, Lebanon, Kenya, Libya, and others. The Chemicals segment offers active pharmaceutical ingredients, excipients, and bio-pharmaceuticals for pharma and biopharma industries; bulk drug products, such as vitamin E, guaizulene, and thaimine disulphide; effect pigments for the automotive, cosmetics, plastics printing, and security industries; actives for the cosmetics industry; and functional and pearl lustre effect pigments. The company was formerly known as E. Merck Limited. The company was founded in 1967 and is based in Mumbai, India. Merck Limited is a subsidiary of Merck KGaA.

1,515 Employees
Last Reported Date: 03/17/15
Founded in 1967

merck ltd (EMER) Top Compensated Officers

Chief Financial Officer, Executive Director o...
Total Annual Compensation: 10.1M
Compensation as of Fiscal Year 2014.

merck ltd (EMER) Key Developments

Merck Ltd. Reports Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended June 30, 2015

Merck Ltd. reported unaudited standalone earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported net sales of INR 2,407.863 million, profit from operations before other income finance costs and exceptional items of INR 262.661 million, profit from ordinary activities before tax of INR 262.661 million and net profit of INR 188.598 million or INR 10.16 per basic and diluted share after extraordinary items (not annualized) compared to net sales of INR 2,326.480 million, profit from operations before other income finance costs and exceptional items of INR 316.318 million, profit from ordinary activities before tax of INR 316.318 million and net profit of INR 209.983 million or INR 12.65 per basic and diluted share after extraordinary items (not annualized) reported in the same period last year. For the six months, the company reported net sales of INR 4,304.743 million, profit from operations before other income finance costs and exceptional items of INR 397.133 million, profit from ordinary activities before tax of INR 397.133 million and net profit of INR 264.792 million or INR 15.95 per basic and diluted share after extraordinary items (not annualized) compared to net sales of INR 4,198.000 million, profit from operations before other income finance costs and exceptional items of INR 376.518 million, profit from ordinary activities before tax of INR 376.518 million and net profit of INR 245.551 million or INR 14.79 per basic and diluted share after extraordinary items (not annualized) reported in the same period last year.

Merck Announces Executive Changes

Merck has announced the appointment of Isabel Paoli, currently head of group strategy, as the new head of group communications, effective March 9, 2016. In her new role, she will be responsible for all global communications at Merck. Walter Huber, who currently holds the position, will retire following the Group's annual earnings press conference on March 8, 2016. On August 1, 2015, Isabel De Paoli will hand over operational responsibility for Group Strategy, which since the beginning of the year has also included Group Organization, to Heiko Schon. Isabel De Paoli will use the time until March 2016 to prepare for her new role. Isabel De Paoli joined Merck in August 2006 as Business Development Manager Chemicals and since January 2012, she has been responsible for Group Strategy.

Merck Ltd., Board Meeting, Aug 12, 2015

Merck Ltd., Board Meeting, Aug 12, 2015. Agenda: To consider and approve the quarterly results; and to amend d its existing code on prevention of insider trading to include inter-alia code of practices of fair disclosure of un-published price sensitive information.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EMER:IN 753.20 INR -13.85

EMER Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Gilead Sciences Inc $101.49 USD -3.58
Koninklijke DSM NV €45.42 EUR -1.49
Lonza Group AG SFr.128.60 CHF -4.00
Sigma-Aldrich Corp $139.44 USD +0.03
Thermo Fisher Scientific Inc $121.75 USD -3.62
View Industry Companies
 

Industry Analysis

EMER

Industry Average

Valuation EMER Industry Range
Price/Earnings 26.9x
Price/Sales 1.4x
Price/Book 2.1x
Price/Cash Flow 19.8x
TEV/Sales 1.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MERCK LTD, please visit www.merck.co.in. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.